Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of NF1-related Plexiform Neurofibroma With Trametinib; a Single Arm, Open-label Trial With the Goals of Volumetric Partial Remission and Pain Relief

NCT03741101 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT03741101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03741101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of NF1-related Plexiform Neurofibroma With Trametinib; a Single Arm, Open-label Trial With the Goals of Volumetric Partial Remission and Pain Relief
Lead sponsor
Region Skane
Phase
Phase 2
Overall status
Unknown status
Start date
June 10, 2019
Completion date
December 15, 2024
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

child, neurofibroma, plexiform, neurofibromatosis 1